OS Therapies OSTX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by OS Therapies in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about OS Therapies's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OS Therapies's financing cash flow?
- OS Therapies (OSTX) reported financing cash flow of $5.21M in Q1 2026.
- How has OS Therapies's financing cash flow changed year-over-year?
- OS Therapies's financing cash flow increased by 394.9% year-over-year, from $1.05M to $5.21M.
- What is the long-term trend for OS Therapies's financing cash flow?
- Over 2 years (2023 to 2025), OS Therapies's financing cash flow has grown at a 81.3% compound annual growth rate (CAGR), from $2.87M to $9.44M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.